Biden won’t benefit from his own Cancer Moonshot:
$150M+ for cutting-edge cancer research
mRNA vaccine trials
tumor-removal tech
ARPA-H is pushing personalized treatments built on COVID-era breakthroughs. The goal? Cut cancer deaths by 50% in 25 years
That’s good governance. That’s Biden's legacy